JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
Microsoft
MSFT
|
+$6.27B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.61B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.32B |
| 4 |
Meta Platforms (Facebook)
META
|
+$3.21B |
| 5 |
Apple
AAPL
|
+$2.9B |
Top Sells
| 1 |
iShares Short Treasury Bond ETF
SHV
|
+$3.23B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.76B |
| 3 |
Schwab US TIPS ETF
SCHP
|
+$702M |
| 4 |
Nike
NKE
|
+$702M |
| 5 |
Tesla
TSLA
|
+$652M |
Sector Composition
| 1 | Technology | 20.52% |
| 2 | Healthcare | 11.04% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.87% |
| 5 | Industrials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4126
Monte Rosa Therapeutics
GLUE
$391M
| $174K | ﹤0.01% |
25,428
+1,028
| +4% | +$7.04K |
|
4127
Parke Bancorp
PKBK
$261M
| $174K | ﹤0.01% |
10,238
+1,653
| +19% | +$28.1K |
|
4128
Kodiak Sciences
KOD
$503M
| $174K | ﹤0.01% |
25,148
-577
| -2% | -$3.98K |
|
|
ORTX
4129
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $173K | ﹤0.01% |
33,419
-14,806
| -31% | -$76.8K |
|
4130
Nathan's Famous
NATH
$421M
| $172K | ﹤0.01% |
2,194
-1,347
| -38% | -$106K |
|
4131
Fossil Group
FOSL
$161M
| $172K | ﹤0.01% |
67,006
+21,999
| +49% | +$56.5K |
|
4132
Matrix Service
MTRX
$360M
| $172K | ﹤0.01% |
29,176
-41,084
| -58% | -$242K |
|
|
IFN
4133
India Fund
IFN
$601M
| $172K | ﹤0.01% |
10,351
+10,343
| +129,288% | +$172K |
|
4134
BRC Inc
BRCC
$189M
| $172K | ﹤0.01% |
33,297
-1,335
| -4% | -$6.89K |
|
4135
Pure Cycle
PCYO
$274M
| $172K | ﹤0.01% |
15,598
+681
| +5% | +$7.49K |
|
|
AKTS
4136
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $171K | ﹤0.01% |
53,873
+2,715
| +5% | +$8.63K |
|
4137
Harvard Bioscience
HBIO
$20.9M
| $171K | ﹤0.01% |
31,189
+30,331
| +3,535% | +$167K |
|
4138
Alpha Tau Medical
DRTS
$348M
| $171K | ﹤0.01% |
39,180
-19,397
| -33% | -$84.8K |
|
4139
Cardlytics
CDLX
$129M
| $171K | ﹤0.01% |
27,052
-40,873
| -60% | -$258K |
|
4140
Immuneering
IMRX
$385M
| $170K | ﹤0.01% |
16,782
+15,752
| +1,529% | +$160K |
|
|
NRT
4141
North European Oil Royalty Trust
NRT
$47.1M
| $169K | ﹤0.01% |
+13,028
| New | +$169K |
|
4142
Norwood Financial Corp
NWFL
$246M
| $169K | ﹤0.01% |
5,723
-524
| -8% | -$15.5K |
|
|
HT
4143
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $169K | ﹤0.01% |
27,687
+3,226
| +13% | +$19.6K |
|
4144
Semler Scientific
SMLR
$432M
| $168K | ﹤0.01% |
6,413
+4,439
| +225% | +$116K |
|
4145
Holley
HLLY
$393M
| $167K | ﹤0.01% |
40,952
-23,682
| -37% | -$96.9K |
|
|
QIPT
4146
Quipt Home Medical
QIPT
$119M
| $167K | ﹤0.01% |
+31,289
| New | +$167K |
|
|
DLY
4147
DoubleLine Yield Opportunities Fund
DLY
$744M
| $167K | ﹤0.01% |
11,495
-10,887
| -49% | -$158K |
|
|
OTLY
4148
Oatly Group
OTLY
$518M
| $167K | ﹤0.01% |
4,072
+2,502
| +159% | +$103K |
|
4149
BayCom
BCML
$325M
| $166K | ﹤0.01% |
9,981
-8,680
| -47% | -$145K |
|
|
PINE
4150
Alpine Income Property Trust
PINE
$205M
| $166K | ﹤0.01% |
10,234
-60,690
| -86% | -$986K |
|